Interferon Therapy Of Chronic Viral Hepatitis In Children

A.S. Potapov, N.L. Pahomovskaya, G.V. Bolynets, T.S. Chetkina

Interferon therapy of chronic viral hepatitis in children
We presented the experience of Roferon-A (recombinant alfa-2a interferon) administration in 69 children with chronic hepatitis C. The data analysis shows the initial remission occur in 49-61% of children at the end of therapy. Remission in 12 months after completion of treatment remained at 22.8-29.6% of patients. It is emphasized that the hitting probability of prolonged remission significantly increases in case of HCV RNA elimination in early stages of interferon therapy.

Keywords

chronic viral hepatitis C
interferon therapy
Roferon-A
children

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.